Your session is about to expire
← Back to Search
Phase-Based Treatment for Problematic Sexual Behavior
N/A
Recruiting
Research Sponsored by Milton S. Hershey Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, typically 12 weeks.
Awards & highlights
No Placebo-Only Group
Summary
This trial tests a new treatment called Phase-Based Treatment (PBT) for preteen children with problematic sexual behavior. PBT aims to help children understand and change their behaviors using the latest research. The trial will compare PBT to usual treatments to see if it works better.
Who is the study for?
This trial is for children aged 4-12 displaying problematic sexual behavior, with a caregiver willing to participate. Children must have certain scores on the CSBI and KBIT-2 tests and be proficient in English. It's not for those outside this age range, lacking English proficiency, or if the caregiver is suspected of abuse.
What is being tested?
The study compares Phase-based Treatment (PBT) against usual treatments for preteen problematic sexual behavior. This first randomized controlled trial will test if PBT is more effective than standard approaches used currently.
What are the potential side effects?
Since this trial involves psychological treatment methods rather than medication, traditional side effects are not applicable. However, there may be emotional or behavioral responses as part of the therapy process.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, typically 12 weeks.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, typically 12 weeks.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in scores on the Child Sexual Behavior Inventory (CSBI)
Secondary study objectives
Change in scores on the Conduct Problems subscale of the Strengths and Difficulties Questionnaire (SDQ)
Change in scores on the Family Sexuality Index (FSI).
Change in scores on the Sexual Concerns subscale of the Trauma Symptom Checklist for Young Children (TSCYC)
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Experimental TreatmentExperimental Treatment1 Intervention
The experimental treatment is Phase-Based Treatment (PBT) for Problematic Sexual Behavior of Preteen Children, an innovative intervention demonstrating promise in preliminary testing.
Group II: Control TreatmentActive Control1 Intervention
The Control Treatment will utilize a Treatment-as-Usual (TAU) condition designed to mimic the types of treatment generally provided in the community for mental health concerns of children.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for Problematic Sexual Behavior (PSB) in preteen children, such as Phase-Based Treatment (PBT), utilize a structured, sequential approach that targets specific phases of behavior modification. These treatments often involve cognitive-behavioral techniques, psychoeducation, and skills training to address and modify problematic behaviors.
This phased approach is essential for PSB patients as it provides a clear, step-by-step framework that ensures each phase builds on the previous one, facilitating lasting behavioral change and helping patients develop healthier coping mechanisms.
Find a Location
Who is running the clinical trial?
Milton S. Hershey Medical CenterLead Sponsor
510 Previous Clinical Trials
2,796,432 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My child is either under 4 years old or over 12 years old.My caregiver is not fluent in English.My child is between 4 and 12 years old.My caregiver can read, write, and speak English well.My primary caregiver is not willing to be involved in the treatment process.
Research Study Groups:
This trial has the following groups:- Group 1: Experimental Treatment
- Group 2: Control Treatment
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger